APO Research
Talk to an analyst

APO RESEARCH · REPORT

Leuprorelin Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Leuprorelin Drugs Industry Growth and Trends Forecast to 2032

28 December 2025107 pages

Choose your research edition.

Industry ResearchLeuprorelin Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Leuprorelin Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Leuprorelin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leuprorelin Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Leuprorelin Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Leuprorelin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Leuprorelin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Leuprorelin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leuprorelin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Leuprorelin Drugs include Takeda Pharmaceutical, Sun Pharmaceutical, Merck, Livzon Pharmaceutical, Beijing Biote Pharmaceutical, Tolmar, Foresee Pharmaceuticals, Eugia Pharma and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Leuprorelin Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Leuprorelin Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Leuprorelin Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Leuprorelin Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Leuprorelin Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Leuprorelin Drugs Market by Company

Takeda Pharmaceutical

Sun Pharmaceutical

Merck

Livzon Pharmaceutical

Beijing Biote Pharmaceutical

Tolmar

Foresee Pharmaceuticals

Eugia Pharma

Cipla

Accord BioPharma

AbbVie

Leuprorelin Drugs Segment by Type

Tablets

Implants

Injections

Leuprorelin Drugs Segment by Application

Endometriosis

Uterine Fibroids

Central Precocious Puberty

Advanced Prostate Cancer

Other

Leuprorelin Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leuprorelin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leuprorelin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leuprorelin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Leuprorelin Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Leuprorelin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Implants Table 3. Major Company of Injections Table 4. Global Leuprorelin Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Leuprorelin Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Leuprorelin Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Leuprorelin Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Leuprorelin Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Leuprorelin Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Leuprorelin Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Leuprorelin Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Leuprorelin Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Leuprorelin Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Leuprorelin Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Leuprorelin Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Leuprorelin Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Leuprorelin Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Leuprorelin Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Leuprorelin Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Leuprorelin Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Leuprorelin Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Leuprorelin Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Leuprorelin Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Leuprorelin Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Leuprorelin Drugs Industry Trends Table 26. Leuprorelin Drugs Industry Drivers Table 27. Leuprorelin Drugs Industry Opportunities and Challenges Table 28. Leuprorelin Drugs Industry Restraints Table 29. Global Leuprorelin Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Leuprorelin Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Leuprorelin Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Leuprorelin Drugs Sales Share by Company (2021-2026) Table 33. Global Leuprorelin Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Leuprorelin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Leuprorelin Drugs Major Company Production Sites and Headquarters Table 36. Global Leuprorelin Drugs Company, Product Type & Application Table 37. Global Leuprorelin Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Leuprorelin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Leuprorelin Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Leuprorelin Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Leuprorelin Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Leuprorelin Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Leuprorelin Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Leuprorelin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Leuprorelin Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Leuprorelin Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Leuprorelin Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Leuprorelin Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Leuprorelin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Leuprorelin Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Leuprorelin Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Leuprorelin Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Leuprorelin Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Leuprorelin Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Leuprorelin Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Leuprorelin Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Leuprorelin Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Leuprorelin Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Leuprorelin Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Leuprorelin Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Leuprorelin Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Leuprorelin Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Leuprorelin Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Leuprorelin Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Leuprorelin Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Leuprorelin Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Leuprorelin Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Leuprorelin Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Leuprorelin Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Leuprorelin Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Pharmaceutical Company Information Table 73. Takeda Pharmaceutical Business Overview Table 74. Takeda Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda Pharmaceutical Leuprorelin Drugs Product Portfolio Table 76. Takeda Pharmaceutical Recent Development Table 77. Sun Pharmaceutical Company Information Table 78. Sun Pharmaceutical Business Overview Table 79. Sun Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sun Pharmaceutical Leuprorelin Drugs Product Portfolio Table 81. Sun Pharmaceutical Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck Leuprorelin Drugs Product Portfolio Table 86. Merck Recent Development Table 87. Livzon Pharmaceutical Company Information Table 88. Livzon Pharmaceutical Business Overview Table 89. Livzon Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Livzon Pharmaceutical Leuprorelin Drugs Product Portfolio Table 91. Livzon Pharmaceutical Recent Development Table 92. Beijing Biote Pharmaceutical Company Information Table 93. Beijing Biote Pharmaceutical Business Overview Table 94. Beijing Biote Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Beijing Biote Pharmaceutical Leuprorelin Drugs Product Portfolio Table 96. Beijing Biote Pharmaceutical Recent Development Table 97. Tolmar Company Information Table 98. Tolmar Business Overview Table 99. Tolmar Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Tolmar Leuprorelin Drugs Product Portfolio Table 101. Tolmar Recent Development Table 102. Foresee Pharmaceuticals Company Information Table 103. Foresee Pharmaceuticals Business Overview Table 104. Foresee Pharmaceuticals Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Foresee Pharmaceuticals Leuprorelin Drugs Product Portfolio Table 106. Foresee Pharmaceuticals Recent Development Table 107. Eugia Pharma Company Information Table 108. Eugia Pharma Business Overview Table 109. Eugia Pharma Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eugia Pharma Leuprorelin Drugs Product Portfolio Table 111. Eugia Pharma Recent Development Table 112. Cipla Company Information Table 113. Cipla Business Overview Table 114. Cipla Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Cipla Leuprorelin Drugs Product Portfolio Table 116. Cipla Recent Development Table 117. Accord BioPharma Company Information Table 118. Accord BioPharma Business Overview Table 119. Accord BioPharma Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Accord BioPharma Leuprorelin Drugs Product Portfolio Table 121. Accord BioPharma Recent Development Table 122. AbbVie Company Information Table 123. AbbVie Business Overview Table 124. AbbVie Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. AbbVie Leuprorelin Drugs Product Portfolio Table 126. AbbVie Recent Development Table 127. North America Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Leuprorelin Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Leuprorelin Drugs Sales Market Share by Country (2021-2026) Table 130. North America Leuprorelin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Leuprorelin Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Leuprorelin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Leuprorelin Drugs Market Share by Country (2021-2026) Table 135. North America Leuprorelin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Leuprorelin Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Leuprorelin Drugs Sales by Country (2021-2026) & (K Units) Table 139. Europe Leuprorelin Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Leuprorelin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Leuprorelin Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Leuprorelin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Leuprorelin Drugs Market Share by Country (2021-2026) Table 145. Europe Leuprorelin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Leuprorelin Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Leuprorelin Drugs Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Leuprorelin Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Leuprorelin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Leuprorelin Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Leuprorelin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Leuprorelin Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Leuprorelin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Leuprorelin Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Leuprorelin Drugs Sales by Country (2021-2026) & (K Units) Table 159. Latin America Leuprorelin Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Leuprorelin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Leuprorelin Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Leuprorelin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Leuprorelin Drugs Market Share by Country (2021-2026) Table 165. Latin America Leuprorelin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Leuprorelin Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Leuprorelin Drugs Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Leuprorelin Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Leuprorelin Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Leuprorelin Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Leuprorelin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Leuprorelin Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Leuprorelin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Leuprorelin Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Leuprorelin Drugs Distributors List Table 180. Leuprorelin Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Leuprorelin Drugs Image Figure 2. Global Leuprorelin Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leuprorelin Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Leuprorelin Drugs Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Implants Image Figure 8. Global Implants Sales YoY Growth (2021-2032) & (K Units) Figure 9. Injections Image Figure 10. Global Injections Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Leuprorelin Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Leuprorelin Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Leuprorelin Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Leuprorelin Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Leuprorelin Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Leuprorelin Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Leuprorelin Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Leuprorelin Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Leuprorelin Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Leuprorelin Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Leuprorelin Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Leuprorelin Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Leuprorelin Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Endometriosis Image Figure 26. Global Endometriosis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Uterine Fibroids Image Figure 28. Global Uterine Fibroids Sales YoY Growth (2021-2032) & (K Units) Figure 29. Central Precocious Puberty Image Figure 30. Global Central Precocious Puberty Sales YoY Growth (2021-2032) & (K Units) Figure 31. Advanced Prostate Cancer Image Figure 32. Global Advanced Prostate Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Leuprorelin Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Leuprorelin Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Leuprorelin Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Leuprorelin Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Leuprorelin Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Leuprorelin Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Leuprorelin Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Leuprorelin Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Leuprorelin Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Leuprorelin Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Leuprorelin Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Leuprorelin Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Leuprorelin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Leuprorelin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Leuprorelin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Leuprorelin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Leuprorelin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Leuprorelin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Leuprorelin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Leuprorelin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Leuprorelin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Leuprorelin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Leuprorelin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Leuprorelin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Leuprorelin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Leuprorelin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Leuprorelin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Leuprorelin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Leuprorelin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Leuprorelin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Leuprorelin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Leuprorelin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Leuprorelin Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Leuprorelin Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Implants
  • Injections
Applications
  • Endometriosis
  • Uterine Fibroids
  • Central Precocious Puberty
  • Advanced Prostate Cancer
  • Other
Companies covered
  • Takeda Pharmaceutical
  • Sun Pharmaceutical
  • Merck
  • Livzon Pharmaceutical
  • Beijing Biote Pharmaceutical
  • Tolmar
  • Foresee Pharmaceuticals
  • Eugia Pharma
  • Cipla
  • Accord BioPharma
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Leuprorelin Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Leuprorelin Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Leuprorelin Drugs Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Implants
  8. 1.3.3 Injections
  9. 1.4 Global Leuprorelin Drugs Market Size by Type
  10. 1.4.1 Global Leuprorelin Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Leuprorelin Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Leuprorelin Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Leuprorelin Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Leuprorelin Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Leuprorelin Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Leuprorelin Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Leuprorelin Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Leuprorelin Drugs Industry Trends
  2. 2.2 Leuprorelin Drugs Industry Drivers
  3. 2.3 Leuprorelin Drugs Industry Opportunities and Challenges
  4. 2.4 Leuprorelin Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Leuprorelin Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Leuprorelin Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Leuprorelin Drugs Price (2021-2026)
  4. 3.4 Global Leuprorelin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Leuprorelin Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Leuprorelin Drugs Company, Product Type & Application
  7. 3.7 Global Leuprorelin Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Leuprorelin Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Leuprorelin Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Leuprorelin Drugs Tier 1, Tier 2, and Tier 3
4 Leuprorelin Drugs Regional Status and Outlook
  1. 4.1 Global Leuprorelin Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Leuprorelin Drugs Historic Market Size by Region
  3. 4.2.1 Global Leuprorelin Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Leuprorelin Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Leuprorelin Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Leuprorelin Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Leuprorelin Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Leuprorelin Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Leuprorelin Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Leuprorelin Drugs by Application
  1. 5.1 Leuprorelin Drugs Market by Application
  2. 5.1.1 Endometriosis
  3. 5.1.2 Uterine Fibroids
  4. 5.1.3 Central Precocious Puberty
  5. 5.1.4 Advanced Prostate Cancer
  6. 5.1.5 Other
  7. 5.2 Global Leuprorelin Drugs Market Size by Application
  8. 5.2.1 Global Leuprorelin Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Leuprorelin Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Leuprorelin Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Leuprorelin Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Leuprorelin Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Leuprorelin Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Leuprorelin Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Leuprorelin Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Leuprorelin Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Leuprorelin Drugs Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Leuprorelin Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Livzon Pharmaceutical
  20. 6.4.1 Livzon Pharmaceutical Company Information
  21. 6.4.2 Livzon Pharmaceutical Business Overview
  22. 6.4.3 Livzon Pharmaceutical Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Livzon Pharmaceutical Leuprorelin Drugs Product Portfolio
  24. 6.4.5 Livzon Pharmaceutical Recent Developments
  25. 6.5 Beijing Biote Pharmaceutical
  26. 6.5.1 Beijing Biote Pharmaceutical Company Information
  27. 6.5.2 Beijing Biote Pharmaceutical Business Overview
  28. 6.5.3 Beijing Biote Pharmaceutical Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Biote Pharmaceutical Leuprorelin Drugs Product Portfolio
  30. 6.5.5 Beijing Biote Pharmaceutical Recent Developments
  31. 6.6 Tolmar
  32. 6.6.1 Tolmar Company Information
  33. 6.6.2 Tolmar Business Overview
  34. 6.6.3 Tolmar Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tolmar Leuprorelin Drugs Product Portfolio
  36. 6.6.5 Tolmar Recent Developments
  37. 6.7 Foresee Pharmaceuticals
  38. 6.7.1 Foresee Pharmaceuticals Company Information
  39. 6.7.2 Foresee Pharmaceuticals Business Overview
  40. 6.7.3 Foresee Pharmaceuticals Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Foresee Pharmaceuticals Leuprorelin Drugs Product Portfolio
  42. 6.7.5 Foresee Pharmaceuticals Recent Developments
  43. 6.8 Eugia Pharma
  44. 6.8.1 Eugia Pharma Company Information
  45. 6.8.2 Eugia Pharma Business Overview
  46. 6.8.3 Eugia Pharma Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eugia Pharma Leuprorelin Drugs Product Portfolio
  48. 6.8.5 Eugia Pharma Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Leuprorelin Drugs Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 Accord BioPharma
  56. 6.10.1 Accord BioPharma Company Information
  57. 6.10.2 Accord BioPharma Business Overview
  58. 6.10.3 Accord BioPharma Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Accord BioPharma Leuprorelin Drugs Product Portfolio
  60. 6.10.5 Accord BioPharma Recent Developments
  61. 6.11 AbbVie
  62. 6.11.1 AbbVie Company Information
  63. 6.11.2 AbbVie Business Overview
  64. 6.11.3 AbbVie Leuprorelin Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AbbVie Leuprorelin Drugs Product Portfolio
  66. 6.11.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America Leuprorelin Drugs Sales by Country
  2. 7.1.1 North America Leuprorelin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Leuprorelin Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Leuprorelin Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Leuprorelin Drugs Market Size by Country
  6. 7.2.1 North America Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Leuprorelin Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Leuprorelin Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Leuprorelin Drugs Sales by Country
  2. 8.1.1 Europe Leuprorelin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Leuprorelin Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Leuprorelin Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Leuprorelin Drugs Market Size by Country
  6. 8.2.1 Europe Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Leuprorelin Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Leuprorelin Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Leuprorelin Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Leuprorelin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Leuprorelin Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Leuprorelin Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Leuprorelin Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Leuprorelin Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Leuprorelin Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Leuprorelin Drugs Sales by Country
  2. 10.1.1 South America Leuprorelin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Leuprorelin Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Leuprorelin Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Leuprorelin Drugs Market Size by Country
  6. 10.2.1 South America Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Leuprorelin Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Leuprorelin Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Leuprorelin Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Leuprorelin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Leuprorelin Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Leuprorelin Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Leuprorelin Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Leuprorelin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Leuprorelin Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Leuprorelin Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Leuprorelin Drugs Value Chain Analysis
  2. 12.1.1 Leuprorelin Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Leuprorelin Drugs Production Mode & Process
  7. 12.2 Leuprorelin Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Leuprorelin Drugs Distributors
  10. 12.2.3 Leuprorelin Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst